COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FIRST QUARTER FINANCIAL RESULTS
Werte in diesem Artikel
REHOVOT, Israel, May 14, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical aesthetics, today announced that it will report financial results for the first quarter on Wednesday, May 28, 2025, before the opening of the U.S. financial markets.
About CollPlant
CollPlant is a regenerative and aesthetic medicine company ushering in a new era of medical solutions with a focus on 3D bioprinting of tissues and organs, tissue repair and medical aesthetics. The Company's products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant-based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing.
In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, an AbbVie company, the global leader in the dermal filler market.
For more information about CollPlant, visit http://www.collplant.com
Contacts:
CollPlant:
Eran Rotem
Deputy CEO & CFO
Tel: +972-73-2325600
Email: eran@collplant.com
Investors:
Daniel Ferry
Managing Director
LifeSci Advisors, LLC
daniel@lifesciadvisors.com
Logo: https://mma.prnewswire.com/media/2217353/CollPlant_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/collplant-biotechnologies-announces-date-for-first-quarter-financial-results-302455030.html
SOURCE CollPlant
Übrigens: Camden Property Trust und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.
Ausgewählte Hebelprodukte auf Camden Property Trust
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Camden Property Trust
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Nachrichten zu Camden Property Trust
Analysen zu Camden Property Trust
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.09.2017 | Camden Property Trust Buy | Stifel, Nicolaus & Co., Inc. | |
| 07.08.2017 | Camden Property Trust Outperform | RBC Capital Markets | |
| 26.05.2017 | Camden Property Trust Outperform | BMO Capital Markets | |
| 23.01.2017 | Camden Property Trust Equal Weight | Barclays Capital | |
| 16.12.2016 | Camden Property Trust Market Perform | BMO Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.09.2017 | Camden Property Trust Buy | Stifel, Nicolaus & Co., Inc. | |
| 07.08.2017 | Camden Property Trust Outperform | RBC Capital Markets | |
| 26.05.2017 | Camden Property Trust Outperform | BMO Capital Markets | |
| 16.12.2016 | Camden Property Trust Market Perform | BMO Capital Markets | |
| 02.05.2016 | Camden Property Trust Outperform | RBC Capital Markets |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.01.2017 | Camden Property Trust Equal Weight | Barclays Capital | |
| 02.06.2016 | Camden Property Trust Neutral | SunTrust | |
| 04.05.2015 | Camden Property Trust Neutral | Mizuho | |
| 02.02.2006 | Update Camden Property Trust: Hold | KeyBanc Capital Markets / McDonald | |
| 20.01.2006 | Update Camden Property Trust: Neutral | Prudential Securities |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 30.10.2015 | Camden Property Trust Underperform | BMO Capital Markets |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Camden Property Trust nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen